Singapore markets close in 53 minutes

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI)

SES - SES Delayed Price. Currency in USD
Add to watchlist
1.19000.0000 (0.00%)
As of 03:56PM SGT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 2.99B
Enterprise value 2.66B
Trailing P/E 7.39
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)0.87
Price/book (mrq)0.92
Enterprise value/revenue 0.37
Enterprise value/EBITDA 2.77

Trading information

Stock price history

Beta (5Y monthly) 0.93
52-week change 34.39%
S&P500 52-week change 3-9.23%
52-week high 31.2300
52-week low 30.9250
50-day moving average 31.0972
200-day moving average 31.0451

Share statistics

Avg vol (3-month) 3207.37k
Avg vol (10-day) 3371.57k
Shares outstanding 5200M
Implied shares outstanding 6N/A
Float 8423.18M
% held by insiders 10.00%
% held by institutions 10.69%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.07
Forward annual dividend yield 46.27%
Trailing annual dividend rate 30.50
Trailing annual dividend yield 342.02%
5-year average dividend yield 44.41
Payout ratio 446.32%
Dividend date 3N/A
Ex-dividend date 424 May 2022
Last split factor 22:1
Last split date 330 Jun 2010

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Sept 2022

Profitability

Profit margin 11.75%
Operating margin (ttm)8.89%

Management effectiveness

Return on assets (ttm)4.19%
Return on equity (ttm)12.91%

Income statement

Revenue (ttm)7.12B
Revenue per share (ttm)9.27
Quarterly revenue growth (yoy)4.50%
Gross profit (ttm)2.75B
EBITDA 746.71M
Net income avi to common (ttm)836.59M
Diluted EPS (ttm)0.1600
Quarterly earnings growth (yoy)30.80%

Balance sheet

Total cash (mrq)2.35B
Total cash per share (mrq)3.04
Total debt (mrq)112.31M
Total debt/equity (mrq)1.63
Current ratio (mrq)2.58
Book value per share (mrq)8.67

Cash flow statement

Operating cash flow (ttm)301.76M
Levered free cash flow (ttm)276.14M